Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1335, 2002-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Montelukast reduces inflammation, improves QOL in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. :
Prednisolone reduces eosinophilic airway inflammation
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
Montelukast reduces resource use in asthma/SAR
Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. :
Montelukast reduces resource use in asthma/SAR
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 535, 2007-01 ,pp. :
Montelukast offers "comparable asthma control" in paediatric patients
Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. :